A Cu-AMO composite membrane for degrading quinolone antibiotics and its application

By introducing fluorosilane modifiers onto organic membranes to tightly adhere Cu-AMO particles and form Cu-AMO composite membranes, the problems of low stability and low flux of existing Cu-AMO catalytic membranes are solved, achieving efficient oxidation of quinolone antibiotics and adapting to complex aquatic environments.

CN118454483BActive Publication Date: 2026-11-17ZHEJIANG UNIV OF TECH
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410366959.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-28
Publication Date
2026-11-17
Estimated Expiration
2044-03-28

AI Technical Summary

Technical Problem

Existing Cu-AMO catalytic membranes suffer from poor stability, low flux, and low mass transfer rate when degrading quinolone antibiotics. Furthermore, the powdered catalyst is difficult to recover, making it difficult to apply in complex real-world water bodies.

Method used

By introducing the surfactant fluorosilane (PFSS) modifier, Cu-AMO particles are uniformly and tightly adhered and fixed on the organic membrane to form a Cu-AMO composite membrane, which enhances the interaction force, ensures the exposure of active sites, and improves mass transfer efficiency.

Benefits of technology

The prepared Cu-AMO composite membrane exhibits high flux and stability at room temperature, can effectively activate PMS to generate 1O2, achieves efficient oxidative degradation of quinolone antibiotics, adapts to different pH conditions, has broad application prospects, and avoids the problem of powder catalyst recovery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004764511180000011
    Figure HDA0004764511180000011
  • Figure HDA0004764511180000012
    Figure HDA0004764511180000012
  • Figure HDA0004764511180000021
    Figure HDA0004764511180000021
Patent Text Reader

Abstract

This invention discloses a Cu-AMO composite membrane for degrading quinolone antibiotics and its applications. By introducing a surface modifier with functional groups similar to those found in biological organisms, Cu-AMO is adhered and fixed onto an organic membrane using vacuum filtration technology to prepare the Cu-AMO composite membrane. This invention also introduces a surfactant (PFSS) to connect the organic membrane and the inorganic material, resulting in a composite membrane with high permeation flux. The Cu-AMO composite membrane is beneficial for improving the mass transfer efficiency of reactants. The degradation rate of ciprofloxacin by the Cu-AMO composite membrane (100%) is higher than that of Cu-AMO powder (60.2%). In practical wastewater treatment, it increases the mineralization of pollutants, reduces the leaching of metal ions during the catalytic process, avoids secondary pollution, and exhibits strong anti-interference capabilities and broad application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

(I) Technical Field

[0001] This invention relates to a Cu-AMO composite membrane for degrading quinolone antibiotics and its application. (II) Background Technology

[0002] Quinolone antibiotics (FQs), as an emerging pollutant, pose a serious threat to human and ecological health due to their high chemical stability and poor biodegradability, ultimately entering biological ecosystems through the food chain. Therefore, exploring novel, efficient, and environmentally friendly antibiotic treatment technologies is of paramount importance.

[0003] In recent years, advanced oxidation processes (SR-AOP) have demonstrated high oxidation capacity and efficient degradation of recalcitrant organic matter. Persulfate (PMS) has been widely studied and applied in SR-AOP systems due to its ease of activation, strong oxidation potential, and efficient activation effect. PMS can be activated by transition metal catalysts to generate reactive oxygen species (ROS) for wastewater treatment. Of particular interest is manganese oxide (MnO₂). x Due to its variable valence state, natural abundance on Earth, diverse crystal structures, low toxicity, and environmental friendliness, manganese dioxide has proven to be a promising catalyst for PMS activation. Although crystalline MnO2 exhibits good catalytic activity for PMS, its complex preparation process and high energy input limit its practical application. Amorphous manganese dioxide, on the other hand, can readily pass through MnO4 under environmental conditions. - or Mn 2+ It has attracted much attention because it was obtained through a simple redox reaction.

[0004] Studies have shown that transition metal doping can generate abundant oxygen vacancies. These oxygen vacancies play a crucial role in promoting bonding with PMS molecules, accelerating interfacial charge transfer processes, and enhancing the redox cycle between MnIV(s) / MnIII(s) and transition metals, thereby significantly improving catalyst activity. Compared with transition metal ions such as Co and Ni, Cu metal is not only less toxic and lower in cost, but also possesses superior performance due to its lower valence state compared to Fe, Ni, and Co. Theoretically, Cu... + or Cu 2+ The coordination number between the site and the oxygen atom is relatively low, at 0.5 or 1 O atom respectively. 2- Atoms, and Fe 2+ / Fe 3+ Ni 2+ / Ni 3+ or Co 2+ / Co 3+ The corresponding site requires 1 or 1.5 O. 2- Atoms, if Cu + and Cu2+ Occupied Mn 3+ and Mn 4+ Sites, O required to maintain coordination balance 2- This reduces the number of oxygen vacancies, leaving abundant oxygen vacancies. Therefore, by selecting Cu-doped amorphous MnO2, abundant oxygen vacancies can be left while maintaining coordination equilibrium. The formation of oxygen vacancies accelerates electron transfer and promotes... 1 O2 generation. Among the active species generated by Cu-AMO activation of PMS, 1 O2 levels exceeding 52% indicate that pollutants are primarily degraded via non-radical pathways. Non-radical reactive species exhibit better resistance to environmental disturbances and are less prone to annihilation in complex aquatic bodies, thus promoting the application of this catalytic degradation technology in such environments. However, powdered catalysts suffer from drawbacks in heterogeneous reaction systems, such as difficult catalyst recovery and low mass transfer efficiency.

[0005] Currently, the main methods for preparing Cu-AMO catalytic membranes are the blended phase inversion method and the vacuum filtration method. The blended phase inversion method involves incorporating Cu-AMO into the polymer used to prepare the membrane; however, this method can lead to the covering of some of the active sites of Cu-AMO, reducing the catalytic effect. The vacuum filtration technique simply deposits Cu-AMO onto the membrane. Due to the weak interaction between the inorganic and organic membranes, the catalytic membrane exhibits poor stability, low flux, and low mass transfer rate, resulting in a decreased degradation rate.

[0006] Therefore, there is a need to find a coupling technology that effectively combines advanced oxidation technology with membrane separation to overcome these problems. (III) Summary of the Invention

[0007] The purpose of this invention is to provide a Cu-AMO composite membrane for degrading quinolone antibiotics and its applications. By introducing a surface modifier with functional groups similar to those found in biological organisms, Cu-AMO is adhered and fixed onto an organic membrane using vacuum filtration technology to form the Cu-AMO composite membrane. The surfactant, such as fluorosilane (PFSS), utilizes the hydrophobic interactions and encapsulation-like chemical crosslinking activity of the fluoroalkyl and siloxane groups of PFSS to strongly coordinate with the sulfonamides of the organic membrane, enhancing the interaction between the organic membrane and Cu-AMO. This ensures that Cu-AMO is uniformly and tightly dispersed in the pores of the organic membrane, enabling the assembly and growth of Cu-AMO particles on the organic membrane and ensuring the composite membrane exhibits superior stability. The Cu-AMO composite membrane prepared by this invention not only effectively exposes more active sites of Cu-AMO and has high flux, but also effectively activates PMS, generating... 1 O2-dominant active oxygen can oxidize and degrade quinolone antibiotics in wastewater through peroxy radicals and singlet oxygen, thus overcoming the shortcomings of existing catalytic membranes, such as poor stability, low flux, and low mass transfer rate.

[0008] The technical solution adopted in this invention is:

[0009] This invention provides a Cu-AMO composite membrane for degrading quinolone antibiotics, wherein the Cu-AMO composite membrane is prepared according to the following steps:

[0010] (1) Preparation of Cu-AMO particles: Potassium permanganate (KMnO4) aqueous solution and copper sulfate (CuSO4) aqueous solution are added simultaneously to oxalic acid (H2C2O4) aqueous solution, and then ammonium hydroxide aqueous solution is added dropwise. After stirring at 600 rpm for 2 h at room temperature (25-30℃), the mixture is centrifuged (preferably centrifuged at 10000 rpm for 6 min). The precipitate is washed with pure water until the water is clear and then dried (preferably dried overnight at 80℃) to obtain Cu-AMO particles.

[0011] (2) Preparation of Cu-AMO composite membrane: Using polysulfone (PSf) membrane as base membrane, soak it in ultrapure water for 10-24h (preferably 12h), add fluorosilane (PFSS) solution dropwise to one side of the base membrane, let it stand at room temperature for 1-5h (preferably 3h) to deposit, and then rinse the base membrane with ultrapure water to remove unreacted fluorosilane on the surface (preferably 1min) to obtain a fluorosilane-treated flat sheet membrane; put the fluorosilane-treated flat sheet membrane into a vacuum filtration device with the fluorosilane-treated side facing up, add Cu-AMO dispersion, use the vacuum filtration device to deposit Cu-AMO onto the fluorosilane-treated flat sheet membrane, and dry it at 40℃ oven temperature to obtain Cu-AMO composite membrane; the fluorosilane solution is prepared by 10-30% (preferably 30%) ethanol aqueous solution by volume concentration; the Cu-AMO dispersion is prepared by dispersing Cu-AMO particles prepared in step (1) in water.

[0012] Further, in step (1), the concentration of oxalic acid aqueous solution is 0.5 mol / L, the concentration of potassium permanganate aqueous solution is 0.2 mol / L, the concentration of copper sulfate aqueous solution is 0.1 mol / L, and the volume concentration of ammonium hydroxide aqueous solution is 0.05%; the volume ratio of the oxalic acid aqueous solution to the potassium permanganate aqueous solution, the copper sulfate aqueous solution and the ammonium hydroxide aqueous solution is 1:1.2:1:0.08.

[0013] Furthermore, in step (2), the polysulfone membrane is preferably a polysulfone ultrafiltration membrane with a capacity of 50,000 Da.

[0014] Furthermore, after the fluorosilane solution in step (2) is prepared, it is added dropwise at a rate of 3 mL / s.

[0015] Further, in step (2), the fluorosilane solution has a mass concentration of 0.2-30%, preferably 10%, and the amount used is sufficient to cover the surface of the base film. The concentration of the Cu-AMO dispersion is 1-5 mg / mL, preferably 1.41 mg / mL.

[0016] Furthermore, in step (2), the mass amount of Cu-AMO in the Cu-AMO dispersion, calculated based on the area of ​​the substrate film contact surface, is 0.21-1.05 mg / cm². 2 The preferred concentration is 0.84 mg / cm³. 2 .

[0017] Further, step (2) is performed using a mold, which consists of a base made of plexiglass and a circular column; the inner diameter of the outer edge of the base is larger than the outer diameter of the circular column, and the depth of the outer edge of the base is greater than the height of the circular column. The circular column can fit into the inner wall of the outer edge of the base. In use, the base membrane is first placed into the base, and then the circular column is pressed onto the base membrane. PFSS solution is added into the circular column. A polysulfone (PSF) ultrafiltration membrane is used as the base membrane, cut into a circular size, and soaked in ultrapure water for 12 hours. Then it is fixed in the mold base. The newly prepared PFSS solution is added to the mold base. The solution was poured into the annular column of the mold at a rate of 3 mL / s, so that one side of the membrane was in contact with the PFSS solution. It was deposited at room temperature for 3 h. Then the base membrane was taken out and rinsed with ultrapure water to remove unreacted PFSS from the surface, resulting in a PFSS-treated flat sheet membrane. The PFSS-treated flat sheet membrane was placed in a vacuum filtration device with the PFSS-treated side facing up, and Cu-AMO dispersion was added. Cu-AMO was deposited onto the PFSS-treated flat sheet membrane using the vacuum filtration device. It was then dried in an oven at 40 °C to obtain a Cu-AMO composite membrane.

[0018] Furthermore, the outer diameter of the chassis is 11.5cm, the inner diameter is 10.5cm, and the depth is 2cm; the outer diameter of the circular cylinder is 10.5cm, the inner diameter is 8.5cm, and the height is 0.9cm.

[0019] The present invention also provides an application of the Cu-AMO composite membrane in the degradation of quinolone antibiotics. The application is as follows: using a substrate solution containing quinolone antibiotics, peroxymonosulfate (PMS) and water, and using a Cu-AMO composite membrane as a catalyst, the substrate solution flows through the surface of the Cu-AMO loaded on the composite membrane. Part of the substrate solution flows through the surface of the composite membrane, while the other part passes through the composite membrane for filtration. The reaction is carried out at room temperature and 0.4 MPa to achieve the degradation of quinolone antibiotics.

[0020] Furthermore, the quinolone antibiotic is ciprofloxacin, levofloxacin, norfloxacin, fleroxacin, pefloxacin, lomefloxacin, or enoxacin.

[0021] Furthermore, the concentration of quinolone antibiotics in the substrate solution is 3-24 mg / L, and the concentration of peroxymonosulfate is 10 mg / L-90 mg / L; the Cu-AMO loading in the Cu-AMO composite membrane is 0.21 mg / cm³. 2 -1.05mg / cm2 .

[0022] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:

[0023] 1. This invention introduces a surfactant (PFSS) to connect organic membranes and inorganic materials, and the resulting composite membrane has a high permeation flux.

[0024] 2. The Cu-AMO composite membrane prepared by this invention is beneficial to improving the mass transfer efficiency of reactants. The degradation rate of ciprofloxacin by the Cu-AMO composite membrane (100%) is higher than that of Cu-AMO powder (60.2%).

[0025] 3. The Cu-AMO composite membrane prepared in this invention is applied to wastewater containing quinolone antibiotics. Due to the oxygen vacancies introduced by Cu doping, oxygen is generated during the catalytic process. 1 The degradation pathway is dominated by O2 (greater than 52%), while non-radical degradation exhibits higher stability and a relatively long lifespan. Therefore, Cu-AMO composite membranes show a wide range of adaptability under different pH conditions.

[0026] 4. The Cu-AMO composite membrane prepared by this invention has strong anti-interference ability and broad application prospects when applied to actual wastewater treatment.

[0027] 5. This invention effectively avoids the problem of recovering powdered catalysts after water treatment, and its technical feasibility is significantly improved.

[0028] 6. The composite membrane prepared by this invention improves the mineralization of pollutants, reduces the leaching of metal ions during the catalytic process, and avoids the problem of secondary pollution. (iv) Description of the attached drawings

[0029] Figure 1 The image shows a SEM image of the Cu-AMO composite membrane in Example 1; a represents the base membrane; b represents the flat sheet membrane after PFSS treatment; and c represents the Cu-AMO composite membrane.

[0030] Figure 2 A is a photo of the mold; B is a photo of the unfolded mold and B is a photo of the assembled mold.

[0031] Figure 3 This is a schematic diagram of membrane flux detection.

[0032] Figure 4 The graph shows the degradation effect of Cu-AMO composite membrane and Cu-AMO particles on ciprofloxacin in water in Example 1.

[0033] Figure 5The graph shows the mineralization rate of ciprofloxacin in water by Cu-AMO composite membrane and Cu-AMO particles in Example 1; A represents Cu-AMO particles, and B represents Cu-AMO composite membrane.

[0034] Figure 6 This refers to the degradation of quinolone antibiotics by the Cu-AMOm / PMS system in Example 3.

[0035] Figure 7 The graph shows the effect of the composite membrane on the catalytic degradation of CIP under different pH conditions in Example 4.

[0036] Figure 8 The graph shows the effect of the composite membrane on the catalytic degradation of CIP in the presence of different quenchers in Example 6.

[0037] Figure 9 The images show the EPR spectra of different active substances in Example 6.

[0038] Figure 10 This is a graph showing the percentage of different active substances in Example 7. (V) Detailed Implementation

[0039] The present invention will be further described below with reference to specific embodiments, but the scope of protection of the present invention is not limited thereto:

[0040] The ambient temperature described in this invention is 25-30℃.

[0041] Example 1: Preparation and Catalytic Oxidation Performance Testing of Cu-AMO Composite Membranes

[0042] 1. Preparation of Cu-AMO particles

[0043] To 25 mL of 0.5 mol / L oxalic acid aqueous solution (H₂C₂O₄), 30 mL of 0.2 mol / L potassium permanganate (KMnO₄) aqueous solution and 25 mL of 0.1 mol / L copper sulfate (CuSO₄) aqueous solution were added simultaneously, followed by the addition of 2 mL of 0.05% ammonium hydroxide aqueous solution. The mixture was stirred at 600 rpm for 2 h at room temperature, then centrifuged at 10000 rpm for 6 min. The precipitate was washed with pure water until the water was clear and dried overnight at 80 °C to obtain 0.2 g of Cu-AMO particles with an average particle size of 9.3 nm.

[0044] 2. Preparation of Cu-AMO composite membranes

[0045] PFSS solution: Dissolve fluorosilane (PFSS) in a 30% (v / v) aqueous ethanol solution to prepare a 10 wt% (w / w) PFSS solution.

[0046] Cu-AMO dispersion: Add 0.0423g of Cu-AMO particles prepared in step 1 to 30mL of water and disperse evenly by ultrasonication to obtain 30mL of Cu-AMO dispersion.

[0047] The mold consists of a base made of plexiglass and a circular ring. The base has an outer diameter of 11.5cm, an inner diameter of 10.5cm, and a depth of 2cm. The circular ring has an outer diameter of 10.5cm, an inner diameter of 8.5cm, and a height of 0.9cm. The circular ring fits snugly against the inner wall of the base within the base. In use, the base film is first placed in the base, then the circular ring is pressed onto the base film. PFSS solution is added inside the circular ring. Figure 2 As shown.

[0048] Using a polysulfone (PSf) ultrafiltration membrane (Zhongke Ruiyang Membrane Technology (Beijing) Co., Ltd., 50000Da) as the base membrane, cut into... The substrate membrane was shaped into a circular shape and soaked in ultrapure water for 12 hours. It was then fixed in the base of a mold, and a circular ring column was placed on top of the substrate membrane. 30 mL of freshly prepared PFSS solution was rapidly poured (within 10 seconds) into the ring column, ensuring one side of the substrate membrane was in contact with the PFSS solution. Deposition was carried out at room temperature for 3 hours. The substrate membrane was then removed and rinsed with ultrapure water to remove unreacted PFSS, resulting in a PFSS-treated flat sheet membrane. The PFSS-treated flat sheet membrane was placed in a vacuum filtration apparatus with the PFSS-treated side facing up. 30 mL of Cu-AMO dispersion was added, and Cu-AMO was deposited onto the PFSS-treated flat sheet membrane using a vacuum filtration apparatus. The Cu-AMO loading was 0.84 mg / cm³. 2 The Cu-AMO composite film was dried at 40℃ in an oven to obtain the Cu-AMO composite film, with the side containing Cu-AMO as the front side.

[0049] Figure 1 The images show SEM (Scanning Electron Microscopy) images of the Cu-AMO composite film. Image a represents the base film, where the PSf support layer and the PSf layer are clearly visible. The cross-sectional morphology of the membrane pores in the PSf layer is clearly displayed, highlighting the layered structure of the film and the porosity formation within the PSf layer. Image b represents the PFSS-treated flat sheet film, where PFSS particles are observed uniformly deposited on the PSf base film, indicating effective PFSS deposition on the PSf surface and providing a foundation for the subsequent attachment of the Cu-AMO layer. Image c represents the Cu-AMO composite film, showing the morphology of the Cu-AMO layer, which is approximately 5.4 μm thick and tightly attached to the PFSS layer.

[0050] 3. Permeation performance testing of Cu-AMO composite membranes

[0051] The Cu-AMO composite film prepared in step 2 was cut into... The circular membrane is placed face down on a low-pressure membrane flux analyzer (Hangzhou Saifei Membrane Separation Technology Co., Ltd., model SF-SA). The analyzer has a permeate tube on the top, a feed tube on the left, and a concentrate tube on the right. The feed tube is inserted into a beaker containing ultrapure water (feed liquid) and a stir bar, and the beaker is placed on a magnetic stirrer. The concentrate and permeate tubes are then placed in separate beakers to collect the concentrate and permeate after the ultrapure water has passed through the composite membrane. Figure 3 (As shown). Turn on the magnetic stirrer and the testing instrument, adjust the pressure to 0.4 MPa, pre-pressurize with ultrapure water for at least 30 minutes to maintain the instrument pressure at 0.4 MPa, then use cross-flow filtration. After the testing instrument pressure stabilizes at 0.4 MPa, record the volume of ultrapure water effluent from the permeate tube every 20 minutes for 2 hours. Calculate the membrane permeate flux using the formula. Each experiment is repeated three times to ensure accuracy. The flux of the composite membrane prepared in this invention is 92.5 L / m³. 2 ·h·bar.

[0052] 4. Detection of catalytic oxidation performance and mineralization rate of Cu-AMO composite membrane and Cu-AMO particles

[0053] (1) Degradation of ciprofloxacin in water by Cu-AMO composite membrane + PMS system

[0054] The Cu-AMO composite membrane prepared by the method in step 2 (the Cu-AMO loading on the composite membrane is 0.84 mg / cm³) 2 Cut into The circular membrane (with a Cu-AMO loading of 0.02 g) was placed on a low-pressure membrane flux tester. After stabilization using the method in step 3, the pump and ultrapure water in the tube were drained, and the pressure was adjusted to 0 MPa.

[0055] A 1L beaker containing a pre-prepared 3mg / L ciprofloxacin (CIP) aqueous solution (pH 5.65) was placed on a running magnetic stirrer. 0.06g PMS was added to the CIP aqueous solution, and after stirring for 3 seconds, this was used as the feed solution. The low-pressure membrane flux analyzer was quickly turned on, and the pressure was adjusted to 0.4MPa. Cross-flow filtration was then used. At reaction times of 3, 6, 9, 12, 15, 20, 25, and 30 min, 1mL of the permeate was taken, filtered through a 0.22μm organic filter, and added to a 0.5mL vial containing methanol. The ciprofloxacin concentration was detected using ultra-high performance liquid chromatography (UHPLC). Each experiment was repeated three times to ensure accuracy. Results are shown below. Figure 4 The curve is Cu-AMOm+PMS.

[0056] (2) Degradation of CIP by Cu-AMO particles + PMS system: 1 L of 3 mg / L CIP aqueous solution (pH 5.65) was placed in a beaker, followed by the addition of 0.02 g of Cu-AMO particles prepared in step 1 as a catalyst. After stirring evenly, 0.06 g of PMS was added and stirred again. Samples were taken at 3, 6, 9, 12, 15, 20, 25, and 30 min, centrifuged, and 1 mL of the supernatant was filtered through a 0.22 μm organic filter before ultra-high performance liquid chromatography (UHPLC) was used to detect the ciprofloxacin concentration and calculate the CIP degradation rate. Results are shown below. Figure 4 Medium curve Cu-AMO+PMS.

[0057] Ultra-high performance liquid chromatography (UPLC) conditions: Column: Waters T3 column (model parameters: 2.1×100nm), at λ=280nm, mobile phase: acetonitrile∶0.2% formic acid=20∶80 (v:v), column temperature: 30℃, flow rate: 0.1mL / min, injection volume: 5μL.

[0058] Figure 4 In this context, C represents the concentration of CIP at time t, C0 represents the initial concentration of CIP, and C / C0 represents the degradation rate. Figure 4 It can be seen that after 30 minutes of reaction, the degradation rate of CIP by the Cu-AMO composite membrane reached 100%, while the degradation rate of CIP by Cu-AMO particles was only 60.2%, indicating that the composite membrane combined with PMS has a good degradation effect on CIP.

[0059] 5. Mineralization rate

[0060] Take 1 mL of permeate from step (1) and 1 mL of supernatant from step (2), filter them separately using a 0.22 μm organic filter, and add them to a liquid chromatography vial containing 0.5 mL of methanol. Use a total organic carbon analyzer to measure the TOC values ​​before and after the reaction to evaluate the mineralization rate of CIP in the system. Each experiment was repeated three times to ensure the accuracy of the experiment.

[0061] like Figure 5 As shown, the mineralization rate of the Cu-AMO composite film reached 59.1% within 30 minutes. Figure 5 In the B group, the Cu-AMO suspension system only reached about 38.6% within 30 minutes. Figure 5 A) indicates that the utilization rate of PMS is improved within the confined space, resulting in a higher mineralization rate on the membrane.

[0062] 6. Metal ion leaching

[0063] Take 1 mL of permeate from step (1) and 1 mL of supernatant from step (2) respectively, filter them with a 0.22 μm organic filter, and add them to a liquid phase vial containing 0.5 mL of methanol. ICP-OES was used to determine the ion leaching in the system. The results showed that, under the same conditions of Cu-AMO and PMS, the ion leaching of Cu in the Cu-AMO composite membrane was 0.35 mg / L and the ion leaching of Mn was 0.017 mg / L. The ion leaching of Cu was less than 1.4 times the maximum allowable daily discharge concentration specified in the "Standard for Wastewater Discharge from Urban Wastewater Treatment Plants" (GB18918-2002). However, the ion leaching of Cu in the Cu-AMO suspension system was 1.2 mg / L and the ion leaching of Mn was 0.045 mg / L. The ion leaching of Cu was more than 2.4 times the maximum allowable daily discharge concentration specified in the "Standard for Wastewater Discharge from Urban Wastewater Treatment Plants" (GB18918-2002). Therefore, Cu-AMO composite membranes can effectively prevent the leaching of metal ions.

[0064] Example 2: Cu-AMO composite membrane prepared without PFSS and its performance testing

[0065] 1. Preparation of Cu-AMO composite membrane (without PFSS)

[0066] Cu-AMO dispersion: 0.0423g of Cu-AMO particles prepared in step 1 of Example 1 were added to 30mL of water and ultrasonically dispersed to obtain 30mL of Cu-AMO dispersion.

[0067] At room temperature, using a polysulfone (PSf) ultrafiltration membrane (Zhongke Ruiyang Membrane Technology (Beijing) Co., Ltd., 50000Da) as the base membrane, it was cut into... The substrate was spherical in size and soaked in ultrapure water for 12 hours. The soaked substrate was then placed in a vacuum filtration apparatus, and 30 mL of Cu-AMO dispersion was added. The Cu-AMO dispersion was deposited onto the membrane using the vacuum filtration apparatus, with a Cu-AMO loading of 0.84 mg / cm³. 2 The Cu-AMO composite membrane (without PFSS) was obtained by drying in an oven at 40℃.

[0068] 2. Permeation performance testing of Cu-AMO composite membrane (without PFSS)

[0069] Cut the Cu-AMO composite membrane (without PFSS) from step 1 into... The permeation performance of the circular Cu-AMO composite membrane (without PFSS) was tested using the method described in Example 1, and the permeation flux was 25.2 L / m. 2 The result is much smaller than the permeation flux of the Cu-AMO composite membrane with added PFSS, which is ·h·bar.

[0070] 3. Catalytic oxidation performance of Cu-AMO composite membrane (without PFSS)

[0071] The catalytic oxidation performance of the Cu-AMO composite membrane (without PFSS) was tested using the method in Example 1. The results showed that the Cu-AMO composite membrane (without PFSS) / PMS system degraded CIP by only 5% within 30 min, while the Cu-AMO composite membrane / PMS system degraded CIP by 98.5% within 30 min.

[0072] Example 3: Degradation activity of Cu-AMO composite membrane against levofloxacin (LEV), fleroxacin (FLE), pefloxacin (PEF), lomefloxacin (LOM), and enoxacin (ENO)

[0073] In step 4 of Example 1, ciprofloxacin (CIP) was replaced with LEV, FLE, PEF, ENO, and LOM, respectively, while other operations remained the same. The concentrations of levofloxacin, fleroxacin, pefloxacin, lomefloxacin, and enoxacin were detected using ultra-high performance liquid chromatography (UHPLC). Figure 6 As shown, the removal rate is 100%.

[0074] Example 4: Degradation performance of Cu-AMO composite membrane for ciprofloxacin at different pH values

[0075] In step 4 of Example 1, the pH of the ciprofloxacin (CIP) aqueous solution was changed to 3, 5, 7, 9, and 11, respectively, while other operations remained the same. The removal rates of ciprofloxacin by the Cu-AMO composite membrane at pH = 3, 5, 7, 9, and 11 were 100%, 100%, 100%, 94.9%, and 73.5%, respectively. Figure 7 As shown, the Cu-AMO composite membrane has a wide range of pH applications.

[0076] Example 5: Detection of ciprofloxacin degradation by Cu-AMO composite membrane in water from different sources

[0077] The ultrapure water used in step 4 of Example 1 was replaced with surface water, secondary sedimentation tank effluent, and tap water, respectively, while other operations remained the same. The results showed that the removal rates of ciprofloxacin by the Cu-AMO composite membrane in the actual water system were 94.1%, 88.7%, and 96.4%, respectively. The results indicate that the Cu-AMO composite membrane has a stronger ability to resist environmental disturbances.

[0078] Example 6: Effect of different quenchers on the degradation of ciprofloxacin by Cu-AMO composite membrane

[0079] In step 4(2) of Example 1, the CIP aqueous solution was added with different concentrations of ethanol (0, 50, 100, 150 mM MEtOH), different concentrations of tert-butanol (0, 50, 100, 150 mM TBA), different concentrations of p-benzoquinone (0, 0.5, 1, 10 mM p-BQ), and different concentrations of L-histidine (0, 0.5, 1, 10 mM L-His), while other operations remained the same. Ethanol can quench ·OH and SO42-. ·- tert-butanol is used to quench ·OH, and p-benzoquinone is used to quench O2. ·- L-histidine is used to quench 1 O2.

[0080] After reactions of 3, 6, 9, 12, 15, 20, 25, and 30 min, 1 mL of the permeate was filtered through an organic filter and added to a 0.5 mL vial of methanol. The degradation rate of ciprofloxacin was determined using ultra-high performance liquid chromatography (UHPLC) as described in Example 1. Each experiment was repeated three times to ensure accuracy. Figure 8 SO4 can be seen in the system. ·- O2 ·- and 1 O2.

[0081] Figure 9 The EPR experiment further verified this conclusion, and the specific steps are as follows:

[0082] (1) Take 30 mg Cu-AMO particles and 30 mg PMS and place them in 30 mL of 100 mM methanol aqueous solution. After mixing, take 30 μL of the mixture and add 30 μL of 5,5-dimethyl-1-pyrrolline-n-oxide (DMPO). After mixing evenly, use a capillary tube to draw a certain amount of the mixture, put it on a quartz tube, and put it into the EPR sample chamber to test hydroxyl + sulfate radicals / superoxide radicals.

[0083] (2) Take 30 mg Cu-AMO particles and 30 mg PMS and place them in 30 mL of 100 mM methanol aqueous solution. Take 30 μL of sample and add 50 μL of 4-amino-2,2,6,6-tetramethylpiperidine (TEMP). After mixing evenly, use a capillary tube to draw a certain amount of the mixture, put it on a quartz tube, and put it into the EPR sample chamber for testing singlet oxygen free radicals.

[0084] Test results are available Figure 9 As shown, this demonstrates that the Cu-AMO / PMS system forms three active oxides, SO 4. - O2 ·- and 1 O2 plays a crucial role in CIP degradation.

[0085] Example 7: Analyzing the main degradation pathway of the reaction by quantitative detection of active species.

[0086] 1. SO 4. - Quantitative:

[0087] SO by indirect quantitative determination 4. - SO4 was calculated using benzoquinone (p-BQ), the main byproduct of the reaction with hydroxybenzoic acid (p-HBA). .- The specific operating procedure for determining the concentration of p-BQ is as follows: In a 500 mL beaker, add 30 mg of Cu-AMO granules, followed by 0.016 mM p-HBA and 0.08 mM peroxymonosulfate (PMS), and 500 mL of ultrapure water. After reacting at 25 °C for 30 s, every 5 min, use a syringe to remove 1 mL of sample from the beaker, filter it through a 0.22 μm PTFE filter, and immediately quench it with MeOH. Then, use UPLC to determine the p-BQ content at 244 nm. The p-BQ and SO42- content are then measured. 4. - The concentration ratio is 1:1, and the calculated SO 4. - The concentration was 0.0048 mM.

[0088] Ultra-high performance liquid chromatography (UPLC) conditions: Column: Waters T3 column (model parameters: 2.1×100nm), at λ=244nm, mobile phase: methanol∶0.1% formic acid=50∶50 (v:v), column temperature: 30℃, flow rate: 0.1mL / min, injection volume: 5μL.

[0089] 2. Quantitative determination of ·OH:

[0090] Benzoic acid (BA) was used as a marker to quantify the concentration of ·OH. The ·OH concentration was calculated by indirectly quantifying p-HBA, the main byproduct of the reaction between ·OH and BA. The specific procedure was as follows: 500 mL of 0.008 mmol / L benzoic acid (BA) aqueous solution was added to a 500 mL beaker. An N2 aeration tube was immersed in the BA aqueous solution to remove O2 from the solution. Then, 30 mg of Cu-AMO particles and a final concentration of 0.08 mM PMS were added. After reacting at 25 °C for 30 s, 1 mL of sample was taken from the beaker every 5 min using a syringe, filtered through a 0.22 μm PTFE filter, and immediately quenched with MeOH. UPLC was used to determine the concentration ratio of p-HBA to ·OH at 270 nm. The ratio was 1:5.87, and ·OH was not detected.

[0091] Ultra-high performance liquid chromatography (UPLC) conditions: Column: Waters T3 column (model parameters: 2.1×100nm), at λ=270nm, mobile phase: acetonitrile∶0.1% formic acid=15∶85 (v:v), column temperature: 30℃, flow rate: 0.1mL / min, injection volume: 5μL.

[0092] 3. O2 ·- Quantitative:

[0093] Nitrotetrazole blue (NBT) was used as an indicator to quantify O2. ·- The concentration of yellow NBT was determined by O2. ·- The solution was reduced to blue formazan. 500 mL of 0.008 mmol / L nitrotetrazolium blue (NBT) aqueous solution was added to a 500 mL beaker. An N2 aerator was immersed in the NBT aqueous solution to remove O2 from the solution. Then, 30 mg of Cu-AMO particles and a final concentration of 0.08 mM PMS were added. After reacting at 25 °C for 30 s, 1 mL of sample was extracted from the beaker every 5 min using a syringe and filtered through a 0.22 μm PTFE filter. O2 was measured at 259 nm using UV-Vis-DRS. ·- The concentration ratio of O2 to formazan is 4:1. ·- The concentration was 0.0065 mM.

[0094] 4. 1 Quantitative analysis of O2:

[0095] 1,3-Diphenylisobenzofuran (DPBF) was used as the probe. 500 mL of 0.008 mmol / L DPBF aqueous solution was added to a 500 mL beaker. An N2 aeration tube was immersed in the DPBF aqueous solution to remove O2 from the solution. Then, 30 mg of Cu-AMO particles and a final concentration of 0.08 mM PMS were added. After reacting at 25 °C for 30 s, 1 mL of sample was taken from the quartz reactor every 5 min using a syringe and filtered through a 0.22 μm PTFE filter. The results were measured at 410 nm using UV-Vis-DRS, showing the relationship between DPBF and... 1 The O2 concentration ratio is 1:1. 1 The O2 concentration was 0.012 mM.

[0096] Figure 10 The results show that SO4 ·- O2 ·- and 1 The O2 contents were 20%, 28%, and 52%, respectively, indicating that the system was mainly degraded by non-free radicals.

Claims

1. A Cu-AMO composite membrane for degrading quinolone antibiotics, characterized in that, The Cu-AMO composite membrane was prepared according to the following steps: (1) Preparation of Cu-AMO particles: Potassium permanganate aqueous solution and copper sulfate aqueous solution were added to oxalic acid aqueous solution at the same time, and then ammonium hydroxide aqueous solution was added dropwise. The mixture was stirred at 600 rpm for 2 hours at room temperature and then centrifuged. The precipitate was washed with pure water until the water was clear and then dried to obtain Cu-AMO particles. (2) Preparation of Cu-AMO composite membrane: Using polysulfone membrane as base membrane, soak it in ultrapure water for 10-24h, add fluorosilane solution dropwise to one side of the base membrane, let it stand at room temperature for 1-5h to deposit, then rinse the base membrane with ultrapure water to remove unreacted fluorosilane on the surface, and obtain a fluorosilane-treated flat sheet membrane; put the fluorosilane-treated flat sheet membrane into a vacuum filtration device with the fluorosilane-treated side facing up, add Cu-AMO dispersion, use the vacuum filtration device to deposit Cu-AMO onto the fluorosilane-treated flat sheet membrane, and dry it at 40℃ oven temperature to obtain Cu-AMO composite membrane; the fluorosilane solution is prepared by 10-30% ethanol aqueous solution by volume; the Cu-AMO dispersion is prepared by dispersing Cu-AMO particles prepared in step (1) in water.

2. The Cu-AMO composite membrane as described in claim 1, characterized in that, In step (1), the concentration of oxalic acid aqueous solution is 0.5 mol / L, the concentration of potassium permanganate aqueous solution is 0.2 mol / L, the concentration of copper sulfate aqueous solution is 0.1 mol / L, and the volume concentration of ammonium hydroxide aqueous solution is 0.05%. The volume ratio of the oxalic acid aqueous solution to the potassium permanganate aqueous solution, the copper sulfate aqueous solution, and the ammonium hydroxide aqueous solution is 1:1.2:1:0.

08.

3. The Cu-AMO composite membrane as described in claim 1, characterized in that, After the fluorosilane solution is prepared in step (2), it is added dropwise at a rate of 3 mL / s.

4. The Cu-AMO composite membrane as described in claim 1, characterized in that, Step (2) The fluorosilane solution has a mass concentration of 0.2-30%; the Cu-AMO dispersion has a concentration of 1-5 mg / mL.

5. The Cu-AMO composite membrane as described in claim 1, characterized in that, In step (2), the mass amount of Cu-AMO in the Cu-AMO dispersion is 0.21-1.05 mg / cm², calculated based on the area of ​​the contact surface with the base film. 2 .

6. The Cu-AMO composite membrane as described in claim 1, characterized in that, Step (2) is performed using a mold, which consists of a base made of plexiglass and a circular cylinder. The inner diameter of the outer edge of the base is larger than the outer diameter of the circular cylinder, and the depth of the outer edge of the base is greater than the height of the circular cylinder. The circular cylinder can fit into the inner wall of the outer edge of the base. In use, the base membrane is first placed into the base membrane, and then the circular cylinder is pressed onto the base membrane. A fluorosilane solution is added into the circular cylinder. A polysulfone ultrafiltration membrane is used as the base membrane, cut into a circular size, and soaked in ultrapure water for 12 hours. Then it is fixed in the mold base. The newly prepared fluorosilane solution is added at 3... The solution is poured into the annular column of the mold at a rate of mL / s, so that one side of the membrane is in contact with the fluorosilane solution. It is deposited at room temperature for 3 hours. Then the base membrane is taken out and rinsed with ultrapure water to remove unreacted fluorosilane from the surface, resulting in a fluorosilane-treated flat sheet membrane. The fluorosilane-treated flat sheet membrane is placed in a vacuum filtration device with the fluorosilane-treated side facing up, and Cu-AMO dispersion is added. Cu-AMO is deposited onto the fluorosilane-treated flat sheet membrane using a vacuum filtration device. It is then dried in an oven at 40°C to obtain a Cu-AMO composite membrane.

7. The Cu-AMO composite membrane as described in claim 6, characterized in that, The outer diameter of the chassis is 11.5cm, the inner diameter is 10.5cm, and the depth is 2cm; the outer diameter of the circular cylinder is 10.5cm, the inner diameter is 8.5cm, and the height is 0.9cm.

8. The application of the Cu-AMO composite membrane according to claim 1 in the degradation of quinolone antibiotics, characterized in that, The application involves using a substrate solution containing quinolone antibiotics, peroxymonosulfate, and water, and a Cu-AMO composite membrane as a catalyst. The substrate solution flows through the surface of the Cu-AMO-loaded composite membrane, with a portion of the substrate solution flowing over the surface of the composite membrane and the other portion passing through the composite membrane for filtration. The reaction is carried out at room temperature and 0.4 MPa to achieve the degradation of quinolone antibiotics.

9. The application as described in claim 8, characterized in that, The quinolone antibiotics mentioned are ciprofloxacin, levofloxacin, norfloxacin, fleroxacin, pefloxacin, lomefloxacin, or enoxacin.

10. The application as described in claim 8, characterized in that, The substrate solution contains quinolone antibiotics at a concentration of 3-24 mg / L and peroxymonosulfate at a concentration of 10 mg / L-90 mg / L; the Cu-AMO loading in the Cu-AMO composite membrane is 0.21 mg / cm³. 2 -1.05mg / cm 2 .

Citation Information

Patent Citations

  • Preparation method and application of ternary heterojunction photocatalytic membrane

    CN115106105A

  • Surface segregation anti-pollution photocatalytic membrane and preparation method thereof

    CN116371207A